Semaglutide may be unsuitable or require additional caution in patients who: are pregnant, breastfeeding or trying to conceive have a history of pancreatitis have severe gastrointestinal disease have delayed stomach emptying have significant kidney or liver impairment use insulin or medicines that can cause hypoglycaemia have diabetic retinopathy have an active or previous eating disorder have experienced a serious allergic reaction to semaglutide already use another GLP-1 or GIP/GLP-1 medicine are due to undergo surgery, sedation or general anaesthesia These factors are not all automatic exclusions
Majeed, A., Majeed, S., Satish, G., Manjunatha, R., Rabbani, S
This may increase food cravings and cause your body to store fat
Importantly, it does not typically drive insulin release under low-glucose conditions, reducing hypoglycemia risk in research settings
Check that your tirzepatide vial or pen is at room temperature before injecting
To further delineate pathways that are responsive to GSTO1 knockdown, we performed gene set enrichment analysis (GSEA) using the Bru-seq data (Supplementary Tables 12 and 13)